Ibugrip Plus

Pseudoephedrine Hydrochloride, the active ingredient in Ibugrip Plus, is a NSAID and sympathomimetic decongestant presented as an oral tablet for systemic use. It combines analgesic, antipyretic and nasal decongestant actions to relieve headache, fever, minor musculoskeletal pain and congestion associated with colds or allergic rhinitis.

GNH USA supplies Ibugrip Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and offering reliable global distribution.

Ibugrip Plus, containing ibuprofen and pseudoephedrine, is used to manage pain, fever and nasal congestion across common cold and allergic conditions. - Headache: provides analgesic relief by reducing pain signaling. - Fever: lowers elevated body temperature through antipyretic action. - Minor musculoskeletal pain: eases soreness and inflammation. - Nasal congestion due to common cold: reduces swelling of nasal mucosa for clearer breathing. - Nasal congestion due to allergic rhinitis: diminishes allergic swelling and blockage.

Ibugrip Plus may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Dizziness - Headache - Dry mouth

Serious or Rare Side Effects: - Anaphylactic reaction (severe allergy) - Gastrointestinal bleeding or ulceration - Significant elevation of blood pressure - Cardiac arrhythmia or palpitations

Before using Ibugrip Plus, consider the following precautions to minimize risk. - Read label: follow all instructions and warnings provided. - Avoid in: patients with known hypersensitivity to ibuprofen or pseudoephedrine. - Consult healthcare professional: if you have hypertension, heart disease, diabetes, thyroid disorders, or are taking anticoagulants. - Pregnancy and breastfeeding: discuss with a doctor before use. - Drug interactions: review concomitant medications for potential conflicts. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Ibugrip Plus can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: increased bleeding risk. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may reduce pseudoephedrine efficacy. - Diuretics: may potentiate blood pressure changes. - Lithium: pseudoephedrine may increase lithium serum levels.